KLK3 and Familial prostate cancer: Furthermore, we did not incorporate covariates for projections of some specific cancers with potential overdiagnosis (e.g., PSA screening rate for prostate cancer and breast cancer screening rates for female breast cancer) as doing so would require further assumptions for projecting these covariates into the future, thereby risking more uncertainty.